97 related articles for article (PubMed ID: 23978918)
1. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia.
Alrajhi AA; Abdulwahab S; Almodovar E; Al-Abdely HM
Neurosciences (Riyadh); 2002 Apr; 7(2):99-104. PubMed ID: 23978918
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia.
Alrajhi AA; Abdulwahab S; Almodovar E; Al-Abdely HM
Saudi Med J; 2002 Mar; 23(3):305-10. PubMed ID: 11938422
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia.
Kordy FN; Al-Thawadi S; Alrajhi AA
Int J Tuberc Lung Dis; 2004 Aug; 8(8):1007-11. PubMed ID: 15305485
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis susceptibility in Saudi Arabia.
Alrajhi AA; Al-Barrak AM
Saudi Med J; 2002 Oct; 23(10):1227-31. PubMed ID: 12436127
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
Al-Rubaish AM; Madania AA; Al-Muhanna FA
Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
[TBL] [Abstract][Full Text] [Related]
6. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
[TBL] [Abstract][Full Text] [Related]
7. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
8. The emergence of drug-resistant tuberculosis in New York City.
Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
[TBL] [Abstract][Full Text] [Related]
9. Status of antituberculosis drug resistance in Saudi Arabia 1979-98.
Abu-Amero KK
East Mediterr Health J; 2002; 8(4-5):664-70. PubMed ID: 15603050
[TBL] [Abstract][Full Text] [Related]
10. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
11. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
12. [Mycobacterium tuberculosis drug resistance in patients with HIV and pulmonary tuberculosis infections in Rome: 1987-1996].
Palmieri F; Pellicelli AM; Girardi E; Rianda A; Bordi E; Festa A; Catania S; D'Amato C
Ann Ital Med Int; 1998; 13(3):139-45. PubMed ID: 9859569
[TBL] [Abstract][Full Text] [Related]
13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
14. [Drug resistance testing of Mycobacterium tuberculosis isolates from sputum in Chad].
Abdelhadi O; Ndokaïn J; Ali MM; Friocourt V; Mortier E; Heym B
Bull Soc Pathol Exot; 2012 Feb; 105(1):16-22. PubMed ID: 21960358
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
16. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005).
Aisenberg GM; Jacobson K; Chemaly RF; Rolston KV; Raad II; Safdar A
Cancer; 2005 Dec; 104(12):2882-7. PubMed ID: 16245341
[TBL] [Abstract][Full Text] [Related]
17. [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors].
Sifuentes-Osornio J; Ponce-de-León LA; Camacho-Mezquita FE; Bobadilla-del-Valle JM; Infante-Suárez ML; Ramírez-Fernández N; Hernández-Gómez L; Nelson AM
Rev Invest Clin; 1995; 47(4):273-81. PubMed ID: 8525129
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
Borchardt J; Kirsten D; Jörres R; Kroeger C; Magnussen H
Pneumologie; 1996 Jan; 50(1):28-35. PubMed ID: 8774932
[TBL] [Abstract][Full Text] [Related]
20. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
Aung WW; Ti T; Than KK; Thida M; Nyein MM; Htun YY; Maung W; Htun A
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):104-10. PubMed ID: 17539254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
